Blood Collection Device Market was valued at USD 8.22 billion in 2017 and is estimated to grow at a CAGR of 6.5% from 2017 to 2024. The Blood Collection Device Market is being anticipated to take advantage of the growing awareness about blood donation through various government initiatives. This could eventually increase the demand for blood products and thus produce quality business opportunities in the Blood Collection Device Market. In addition to manual blood collection, other methods such as automatic blood collection should be widely available worldwide. Players seeking to enter the market could benefit from these advances in the industry. The growth in the blood collection device segment is due to the increasing prevalence of blood disorders, the increasing demand for biopharmaceutical plasma for plasma fractionation, for apheresis devices, whole blood sampling in emerging economies. Blood collection involves taking blood samples from the donor to perform diagnostic tests in the laboratory and treat patients. The Blood Collection Device Market is segmented by product, method, end user, and region. The blood collection tubes are segmented by tube type as plasma separation tube, heparin tubes, serum separator tubes, EDTA tubes, rapid serum tubes, and others. Serum separation tubes have the largest market share followed by EDTA tubes. This is due to the factors such as collection of more serum samples and used for various diagnostic applications. Geographically, North America has been the largest market for blood collection, due to heightened awareness, the established health care industry and the growing prevalence of infectious and non-infectious diseases in the region. The United States contributed the most to the revenue from the Blood Collection Device Market in North America and globally. The presence of a large number of diagnostic laboratories and hospitals and the increasing prevalence of people with blood disorders are the main growth factors for the US Blood Collection Device Market. The key players in the Blood Collection Device Market include Becton, Dickinson and Company (US), Medtronic (US), Fresenius (Germany), Nipro Medical (US), F.L. Medical (Italy), Smiths Medical (US), Grifols (Spain), Kawasumi Laboratories (Japan), and Quest Diagnostics (US). The years that have been considered for the study are: • Base year – 2016 • Estimated year – 2017 • Forecast period – 2017 to 2024 Target Audience: • Healthcare service providers (hospitals and pathology laboratories) • Blood collection product manufacturers • Blood banks • NGOs and government organizations associated with blood collection • Market research and consulting firms
Blood Collection Device Market - Key Segments:
Blood Collection Device Market, By Product:• Blood Collection Tubes: o Serum Collection Tubes o Plasma or Whole Blood Collection tubes EDTA Tubes Heparin Tubes Coagulation Tubes Glucose Tubes ESR Tubes • Needles and Syringes • Blood Bags • Blood Collection Devices • Lancets
Blood Collection Device Market, By Method:• Manual Blood Collection • Automated Blood Collection
Blood Collection Device Market, By End User:• Hospitals • Clinical Laboratories • Pharmaceutical and Biotechnology Companies & Contract Research Organizations (CROs) • Blood Banks • Research & Academic Laboratories • Others
Blood Collection Device Market - Company Profiles:• Becton, • Dickinson and Company (US) • Medtronic (US) • Fresenius (Germany) • Nipro Medical (US) • F.L. Medical (Italy) • Smiths Medical (US) • Grifols (Spain) • Kawasumi Laboratories (Japan) • aQuest Diagnostics (US).
Blood Collection Device Market, By Region:North America: • U.S • Canada Europe: • Germany • France • UK • Italy • Spain • Russia • Rest of Europe Asia Pacific: • Japan • China • India • South Korea • Australia • Rest of Asia Pacific Rest of the World (ROW): • Middle-East • Africa • Latin America Global Monoclonal Antibodies (mAbs) Market